Company Description
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments.
It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.
The company has a collaboration with SkyWaterTechnology for the development of consumable for Proteus, that will enable simultaneous protein sequencing.
Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 159 |
| CEO | Jeffrey Hawkins |
Contact Details
Address: 29 Business Park Drive Branford, Connecticut 06405 United States | |
| Phone | 866 688 7374 |
| Website | quantum-si.com |
Stock Details
| Ticker Symbol | QSI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001816431 |
| CUSIP Number | 74765K105 |
| ISIN Number | US74765K1051 |
| Employer ID | 85-1388175 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Alan Hawkins | President, Chief Executive Officer and Director |
| Dr. Jonathan M. Rothberg Ph.D. | Founder and Executive Director |
| Jeffry R. Keyes CPA | Chief Financial Officer and Treasurer |
| Todd Rearick | Chief Technology Officer |
| Juan Esteban Avendano | Vice President of Investor Relations |
| Dr. Christian Lapointe J.D., Ph.D. | General Counsel and Corporate Secretary |
| Alex A. Hutcheson | Senior Vice President of Sales and Service |
| Katherine Atkinson | Senior Vice President of Demand Generation and Corporate Brand |
| Johan Denecke | Senior Vice President of Operations |
| John S. Vieceli | Chief Product Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 11, 2024 | 8-K | Current Report |
| Dec 11, 2024 | 424B5 | Filing |
| Dec 9, 2024 | 8-K | Current Report |
| Nov 22, 2024 | 8-K | Current Report |
| Nov 21, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K/A | [Amend] Current report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 8, 2024 | 8-K | Current Report |
| Sep 17, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |